Kissei Pharmaceutical Co (JP:4547) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kissei Pharmaceutical Co reported a 14.8% increase in net sales for the second quarter of Fiscal 2024, driven by its Pharmaceutical Business, despite a decline in operating profit due to rising R&D expenses. The company’s expansion of key and new products contributed significantly to the sales growth.
For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.